Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oncology Institute Equity Warrant Exp 15th Nov 2026 TOIIW

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including... see more

Recent & Breaking News (NDAQ:TOIIW)

The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call

GlobeNewswire April 19, 2023

CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

GlobeNewswire March 16, 2023

The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

GlobeNewswire March 9, 2023

The Oncology Institute to Participate at Upcoming Investor Conferences

GlobeNewswire February 28, 2023

The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call

GlobeNewswire February 16, 2023

The Oncology Institute Expands Into Chino, CA

GlobeNewswire December 19, 2022

The Oncology Institute Rebrands Clinical Trials Division

GlobeNewswire December 15, 2022

The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa

GlobeNewswire November 22, 2022

The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance

GlobeNewswire November 9, 2022

The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference

GlobeNewswire November 1, 2022

The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call

GlobeNewswire October 19, 2022

The Oncology Institute Executives to Speak at Key Industry Conferences in Q4

GlobeNewswire October 17, 2022

The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials

GlobeNewswire October 11, 2022

The Oncology Institute Expands into South Florida

GlobeNewswire October 6, 2022

The Oncology Institute Enrolls Nation's First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib

GlobeNewswire September 29, 2022

The Oncology Institute Appoints Two New Board Members

GlobeNewswire September 22, 2022

The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium

GlobeNewswire September 15, 2022

The Oncology Institute Becomes Certified as a Patient Safety Organization

GlobeNewswire September 12, 2022

The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms

GlobeNewswire August 22, 2022

The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day

GlobeNewswire August 16, 2022